DISCLAIMER ! NAFDAC DIRECTOR GENERAL PROFESSOR ADEYEYE SAYS PAX HERBAL (PAX CVD PLUS) NOT APPROVED FOR COVID-19 TREATMENT

03/05/20,

[post-marguee]

DANIELS G O

THE DIRECTOR GENERAL OF THE NATIONAL AGENCY FOR FOOD AND DRUG ADMINISTRATION AND CONTROL NAFDAC PROFESSOR MOJISOLA ADEYEYE HAS DISSOCIATED THE AGENCY FROM AN GOING ADVERTORIALS ABOUT AN HERBAL CURE FOR CORONA VIRUS IN NIGERIA

PROFESSOR ADEYEYE IN A PRESS RELEASE SAID THE CLAIMS THAT PAX HERBAL HAS DEVELOPED A NEW DRUG CALLED PAX CVD PLUS FOR THE TREATMENT OF THE DREADED VIRUS IN COLLABORATION WITH NAFDAC WAS NOT TRUE.

THE SAID ADVERTORIALS ALSO CLAIMED THAT THE THE D.G HAS APPOINTED EXPERTS TO WORK WITH PAX HERBAL ON WHAT THE COMPANY HAS DESCRIBED AS A SPECIAL PROJECT.

THE REGULATORY AGENCY URGED THE PUBLIC TO DISREGARD SUCH CLAIMS AS PAX HERBAL CVD PLUS OR ANY OTHER HERBAL CURE HAS NOT BEEN APPROVED OR LISTED FOR TREATMENT BY NAFDAC.

THE DIRECTOR GENERAL HOWEVER NOTED THAT THE COMPANY HAD WRITTEN A LETTER TO NAFDAC INFORMING THEM ABOUT AN ANTI RETROVIRAL PLANT BASED DRUG WITH POTENTIAL TO TREAT COVID-19, AND AN INVITATION TO JOIN THEIR RESEARCH TEAM WHICH THE AGENCY TACTICALLY AVOID SINCE AS A REGULATOR OF CLINICAL TRIALS,PARTICIPATION WOULD AMOUNT TO CONFLICT OF INTEREST.

THE AGENCY SAID IT ENCOURAGED THE COMPANY TO CARRY OUT CLINICAL TRIALS WHICH SHOULD BE UNDER STRICT SUPERVISION OF THE AGENCY TO ESTABLISH THE EFFICACY OF THEIR PRODUCT,WHICH THEY ARE YET TO DO TILL DATE.